GLP-1 Action: Similar to semaglutide, tirzepatide activates GLP-1 receptors, contributing to delayed gastric emptying, appetite suppression, and improved blood sugar regulation
Prevalence and risk factors of diabetic peripheral neuropathy in Chinese communities
JCI insight
Visible weight changes typically begin in weeks three to four
Cynthia Maxwell MD, MBA, FRCSC, DABOM (Obesity Medicine), is the Medical Content Director of First Exposure, the Vice President, Medical Affairs & System Transformation and Lead Medical Executive at Womens College Hospital and Professor, Faculty of Medicine, Department of Obstetrics and Gynaecology and Division of Maternal Fetal Medicine at the University of Toronto
When compared directly against naltrexone and topiramate the current front-line medications for alcohol use disorder semaglutide users had a 75 percent lower risk of recurrence